Skip to main content

Advertisement

Table 1 Demographic data for women randomized to oral or vaginal metronidazole.

From: Comparison of oral and vaginal metronidazole for treatment of bacterial vaginosis in pregnancy: impact on fastidious bacteria

  Oral treatment
(n = 30)
Vaginal treatment
(n = 23)
P valuea
Age (mean years) 23 20 .17
Raceb    < .01
   White 7 (20%) 7 (30%)  
   African American 13 (43%) 4 (17%)  
   Asian/PI 10 (33%) 4 (17%)  
   Hispanic 0 7 (30%)  
Marital statusc    .60
   Single 12 (40%) 8 (35%)  
   Married/living with 17 (57%) 15 (65%)  
Occupationc    .65
   Student 7 (23%) 8 (35%)  
   Employed 13 (43%) 8 (35%)  
   Unemployed 10 (33%) 7 (30%)  
Education (highest completed)c    .20
   Primary 9 (30%) 10 (43%)  
   Secondary 12 (40%) 4 (17%)  
   Tertiary 9 (30%) 9 (39%)  
History of douching 6 (20%) 2 (9%) .44
Smoker 11 (37%) 11 (48%) .41
Gravidity (median) 2 1 .02
Gestational age at enrollment (median in weeks) 15 16 .51
Gestational age at delivery (median in weeks) 39 40 .78
Birthweight (mean in grams) 3160.5 3203 .94
Clinical cure after treatment
(ie. 0 Amsel's criteria)
17 (57%) 14 (61%) .73
Microbiologic cure after treatment (ie. Nugent score ≤ 3) 16 (53%) 12 (52%) .58
  1. aCategorical variables were analyzed using Chi square or Fisher's exact test. Continuous variables were analyzed using the Mann-Whitney U test.
  2. bPercentages may not add up to 100% because of rounding, or missing data points
  3. cMissing data for some participants